Pacemaker signals may unmask a rare heart condition
NCT ID NCT07734285
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study explores whether the electrical signal measured by a pacemaker or defibrillator during implantation can help identify cardiac amyloidosis — a condition where abnormal proteins build up in the heart. Researchers will enroll 242 adults aged 65 and older who already need a pacemaker due to heart rhythm problems and also have thickened heart walls. Alongside standard implantation, participants will receive extra tests including a heart scan, blood work, and a small fat biopsy to confirm or rule out amyloidosis. The goal is to see if the pacemaker's readings alone can reliably flag the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a simple, low-cost way to screen for cardiac amyloidosis during routine pacemaker implantation.
- What could go wrong
- This is an early diagnostic study, not a treatment trial. The electrical signal test may not prove accurate enough to replace standard biopsies or scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- A carpal tunnel clue to a silent heart threat?
- Heart scans may unlock hidden risks in minority communities
- Could a common blood pressure pill protect the heart after valve replacement?
- Can an AI spot hidden heart disease that doctors miss?
- AI eye on the heart: could a computer catch a rare, Often-Missed disease?